MedTrace Logo

Institut Fuer Diabetes-Technologie Surveillance Program

NCT03737188 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2019-02-26

No results posted yet for this study

Summary

Assessment of the system accuracy of different blood glucose monitoring systems available in Europe

Conditions

Interventions

DEVICE

Blood glucose monitoring systems for self-testing

Capillary blood samples will be used for the evaluation of system accuracy.

Sponsors & Collaborators

  • Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-14
Primary Completion
2018-12-05
Completion
2018-12-05

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03737188 on ClinicalTrials.gov